Abstract | OBJECTIVE: To review a 12-year experience of the world's three largest preimplantation genetic diagnosis ( PGD) centers. DESIGN: Multicenter analysis of the clinical outcome of PGD. SETTING: In vitro fertilization programs at the Reproductive Genetics Institute, Chicago, Illinois; Saint Barnabas Medical Center, West Orange, New Jersey; and SISMER, Bologna, Italy. PATIENT(S): Poor-prognosis IVF patients, patients carrying balanced chromosomal translocations, and couples at risk for producing children with Mendelian disorders. INTERVENTION(S): In vitro fertilization, intracytoplasmic sperm injection, polar body removal, blastomere biopsy, and ET. MAIN OUTCOME MEASURE(S):
DNA or chromosomal analysis of biopsied polar bodies or blastomeres, implantation and clinical pregnancy rates, and live-born pregnancy outcome. RESULT(S): CONCLUSION(S): Preimplantation genetic diagnosis is evolving to become a clinical option for couples at risk for producing offspring with Mendelian diseases, has a positive numerical impact in standard assisted reproduction practices through aneuploidy testing, and reduces by at least fourfold the spontaneous abortion rate in couples carrying translocations.
|
Authors | Yury Verlinsky, Jacques Cohen, Santiago Munne, Luca Gianaroli, Joe Leigh Simpson, Anna Pia Ferraretti, Anver Kuliev |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 82
Issue 2
Pg. 292-4
(Aug 2004)
ISSN: 0015-0282 [Print] United States |
PMID | 15302270
(Publication Type: Journal Article)
|
Topics |
- Blastula
- Female
- Genetic Diseases, Inborn
(genetics, prevention & control)
- Genetic Testing
(trends)
- Humans
- Pregnancy
- Pregnancy Outcome
|